logo

For the Inventor, By the Inventor

Branford, CT, United States of America

Andrew Y Thurkauf

This inventor holds 77 USPTO granted patents and 2 EPO patents, primarily in Dopamine Receptor Ligands (CPC class 5443). Top assignees: Neurogen Corporation, Achillion Pharmaceuticals, Inc., G.d. Searle & Company. Active years: 1992-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrew Y Thurkauf. Retrieved from https://idiyas.com/inventor/andrew-y-thurkauf

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 77

% Patents Active = 70.1


Average Co-Inventor Count = 3.1

ph-index = 12

Forward Citations = 462(Granted Patents)

Forward Citations (Not Self Cited) = 382(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Bradford, CT (US) (1992)
  • Crofton, MD (US) (1993)
  • Laurel, MD (US) (1995 - 1997)
  • Branford, CT (US) (1992 - 1998)
  • Banford, CT (US) (1998)
  • Ridgefield, CT (US) (2006 - 2010)
  • Danbury, CT (US) (1997 - 2012)

Company Filing History:

goldMedal63 out of 305 
 
Neurogen Corporation
 patents
silverMedal6 out of 104 
 
Achillion Pharmaceuticals, Inc.
 patents
bronzeMedal3 out of 1,323 
 
G.d. Searle & Company
 patents
4. 3 out of 1,217 
 
The United States of America as Represented by the Department of Health
 patents
5. 2 out of 29 
 
Novartis International Pharmaceutical, Ltd.
 patents
6. 1 out of 4,488 
 
Pfizer Corporation
 patents
7. 1 out of 3,696 
 
The United States of America, as Represented by the Secretary, Department of Health and Human Services
 patents
8. 1 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 1992-2012

Loading Chart...
Loading Chart...
Areas of Expertise:
C5a Receptor Modulators
Viral Replication Inhibitors
Dopamine Receptor Ligands
Aryl Imidazoles
Amino Methyl Imidazoles
Substituted Aryl Thioureas
Melanin Concentrating Hormone
Pharmaceutical Compositions
Biaryl Amides
Piperazine Derivatives
Aryl Acylthioureas
Imidazole Derivatives
77 patents (USPTO):Explore Patents
1. 8119665 - Aryl imidazoles and related compounds as C5a receptor modulators (2012-02-21),
2. 8007767 - Amino methyl imidazoles and related compounds as C5a receptor modulators (2011-08-30),
3. 7767706 - Substituted aryl acylthioureas and related compounds; inhibitors of viral replication (2010-08-03),
4. 7718671 - Substituted arylthiourea derivatives useful as inhibitors of viral replication (2010-05-18),
5. 7476686 - Substituted aryl thioureas and related compounds; inhibitors of viral replication (2009-01-13),
6. 7439374 - Azabenzofuran substituted thioureas; inhibitors of viral replication (2008-10-21),
7. 7365068 - Substituted aryl acylthioureas and related compounds; inhibitors of viral replication (2008-04-29),
8. 7323478 - Melanin concentrating hormone receptor ligands (2008-01-29),
9. 7271270 - High affinity small molecule C5a receptor modulators (2007-09-18),
10. 7186734 - Aryl imidazoles and related compounds as C5a receptor modulators (2007-03-06),
11. 7169775 - Amino methyl imidazoles as C5a receptor modulators (2007-01-30),
12. 7101887 - 1-phenyl-4-benzylpiperazines dopamine receptor subtype specific ligands (2006-09-05),
13. 7094807 - Substituted aryl thioureas and related compounds; inhibitors of viral replication (2006-08-22),
14. 6884815 - High affinity small molecule C5a receptor modulators (2005-04-26),
15. 6858637 - Substituted biaryl amides as C5a receptor modulators (2005-02-22),

Title: The Innovative Journey of Andrew Y Thurkauf

Introduction: Andrew Y Thurkauf is a distinguished inventor based in Branford, CT (US) known for his groundbreaking contributions to various fields.

Latest Patents: Andrew Y Thurkauf's latest patents include cutting-edge technologies in the healthcare sector, revolutionizing the way medical procedures are conducted.

Career Highlights: With a career spanning over two decades, Andrew Y Thurkauf has established himself as a pioneer in the field of medical device innovations, holding numerous patents that have significantly impacted the industry.

Collaborations: Throughout his career, Andrew Y Thurkauf has collaborated with leading research institutions and universities to further advance his inventions, showcasing his commitment to pushing the boundaries of innovation.

Conclusion: Andrew Y Thurkauf's relentless pursuit of innovation and his passion for creating solutions that improve lives make him a standout figure in the world of inventors.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…